1. Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Cho SH, Raybuck AL, Stengel K, Wei M, Beck TC, Volanakis E, Thomas JW, Hiebert S, Haase VH, Boothby MR (2016) Nature 537(7619): 234-238
    › Primary publication · 27501247 (PubMed) · PMC5161594 (PubMed Central)
  2. Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites. Wan X, Thomas JW, Unanue ER (2016) J Exp Med 213(6): 967-78
    › Primary publication · 27139492 (PubMed) · PMC4886365 (PubMed Central)
  3. B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes. Packard TA, Smith MJ, Conrad FJ, Johnson SA, Getahun A, Lindsay RS, Hinman RM, Friedman RS, Thomas JW, Cambier JC (2016) J Clin Med 5(11)
    › Primary publication · 27834793 (PubMed) · PMC5126795 (PubMed Central)
  4. The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months. Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups (2015) Diabetes Care 38(5): 940-2
    › Primary publication · 25758770 (PubMed) · PMC4407750 (PubMed Central)
  5. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice. Bonami RH, Thomas JW (2015) J Immunol 195(10): 4730-41
    › Primary publication · 26432895 (PubMed) · PMC4637270 (PubMed Central)
  6. Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes. Williams JM, Bonami RH, Hulbert C, Thomas JW (2015) J Immunol 195(3): 853-64
    › Primary publication · 26109644 (PubMed) · PMC4506889 (PubMed Central)
  7. A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history. Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP, Type 1 Diabetes TrialNet Study Group, Diabetes Prevention Trial-Type 1 Study Group (2015) Diabetes Care 38(2): 271-6
    › Primary publication · 25519451 (PubMed) · PMC4302258 (PubMed Central)
  8. NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells. Bonami RH, Wolfle WT, Thomas JW, Kendall PL (2014) Mol Immunol 62(2): 321-8
    › Primary publication · 24507801 (PubMed) · PMC4125564 (PubMed Central)
  9. Tolerant anti-insulin B cells are effective APCs. Kendall PL, Case JB, Sullivan AM, Holderness JS, Wells KS, Liu E, Thomas JW (2013) J Immunol 190(6): 2519-26
    › Primary publication · 23396943 (PubMed) · PMC3652276 (PubMed Central)
  10. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G, Type 1 Diabetes TrialNet Study Group, Diabetes Prevention Trial-Type 1 Study Group (2013) Diabetes Care 36(9): 2615-20
    › Primary publication · 23818528 (PubMed) · PMC3747899 (PubMed Central)